sales

NXP

Innovation Origins: NXP is working on new innovations in record year

Things are going well for NXP, says Dutch top executive Jean Schreurs during a visit to the headquarters in the dutch city of Eindhoven. “The demand for chips is enormous, much greater than NXP or other chip manufacturers are able to supply.”

Lees verder
Smart-Energy

Sumitomo Electric: 400 years history took them to 5G amplifiers

Sumitomo Electric has a long and rich history. It was founded in the 17th century by Masatomo Sumitomo, started working with his brother-in-law.

Lees verder
banner Khondrion vs 3

Khondrion announces that the first patients have been successfully dosed in its KHENEREXT Phase IIb open-label extension study

Khondrion, a clinical-stage biopharmaceutical company discovering and developing therapies targeting primary mitochondrial diseases, today announces that the first patients have been successfully dosed.

Lees verder

NXP Reichswald MTB tour

Elk jaar in de herfst organiseert NXP Cycletime de Reichswald MTB tour. Deze tour neemt je mee over de
beste MTB tracks in de omgeving van Kleve.

Lees verder

Alveron Pharma haalt 3,9 miljoen euro op voor de verdere ontwikkeling van een geneesmiddel tegen levensbedreigende bloedingen

Het geneesmiddel van Alveron is uniek omdat het de effecten van álle belangrijke anticoagulantia omkeert en dus niet specifiek is voor één type antistollingsmiddel.

Lees verder

Alveron Pharma BV raises a further EUR 3.9 million to progress first in class drug

Alveron’s drug is unique as it reverses the effects of all the major anticoagulants (including all DOACs and vitamin K antagonists) and platelet aggregation inhibitors like clopidogrel.

Lees verder
Inscience

InScience Festival: Lust for Life

This years festival will investigate the importance of a healthy life, now and in the future, for humans, animals and the planet.

Lees verder
Artez NXP

Expo ArtEZ-NXP

NXP wants to keep the history of technology alive.

Lees verder

New start-up Patholyt will bring AI research into pathology diagnostics

Patholyt is on a mission to accelerate the adoption of artificial intelligence in pathology diagnostics and improve the chances of cancer patients worldwide.

Lees verder

Start-up Patholyt ontwikkelt AI-innovaties voor de patholoog

Patholyt wil de toepassing van kunstmatige intelligentie (AI) in de pathologie versnellen en de kansen van kankerpatiënten wereldwijd verbeteren.

Lees verder